In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: Application to breakpoint determinations

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 9, 1998, Pages 2375-2379

  Andes, D ^a,b   Craig, W A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; KIDNEY DISEASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA;

EID: 0031684767     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.9.2375     Document Type: Article

References (24)

1. Abboud, M. F., and B. A. Waisbren. 1959. Correlation between in vitro studies and response to antibiotic therapy in staphylococci bacteremia. Am. J. Med. 104:226-233.
2. Asensi, F., D. Perez-Tamarit, M. C. Otero, et al. 1989. Imipenem-cilastin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Pediatr. Infect. Dis. J. 163:895.
3. Barry, B., P. Gehanno, M. Bluman, and I. Boucot. 1993. Clinical outcome of acute otitis media due to Streptococcus pneumoniae with decreased susceptibility to penicillin, abstr. 1373, p. 370. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
4. Block, S., J. Hedrick, C. Harrison, et al. 1993. Penicillin-resistant S. pneumoniae in acute otitis media, abstr. 1046, p. 311. In Program and abstract of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Craig, W. 1993. Relevance of animal models for clinical treatment. Eur. J. Clin. Microbiol. Infect. Dis. 12(Suppl. 1):55-57.
6. Craig, W. A., J. Redington, and S. C. Ebert. 1991. Phamacodynamics of amikacin in vitro and in mouse thigh and lung infections. J. Antimicrob. Chemother. 27(Suppl. C):29-40.
7. Craig, W. A., and D. R. Andes. 1996. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15:255-259.
8. Craig, W. A., S. Ebert, and Y. Wantanabe. 1993. Differences in time above MIC required for efficacy of beta-lactams in animal models, abstr. 86, p. 135. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
9. Craig, W. A. 1995. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn. Microbiol. Infect. Dis. 22:89-93.
10. Dagan, R., O. Abramason, E. Leibovitz, D. Greenberg, R. Lang, S. Goshen, P. Yagupsky, A. Leiberman, and D. M. Fliss. 1997. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J. Infect. Dis. 176:1253-1259.
11. Friedland, I. R., S. Shelton, M. Paris, et al. 1993. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 12:196-200.
12. Frimodt-Moller, N., M. W. Bentzon, and V. F. Thomsen. 1986. Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. J. Infect. Dis. 154:511-517.
13. Gehanno, P., G. Lenoir, and P. Berche. 1994. In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob. Agents Chemother. 39:271-272.
14. Giacomini, K., S. M. Roberts, and G. Levy. 1981. Evaluation of methods for producing renal dysfunction in rats. J. Pharm. Sci. 70:117-121.
15. Hoberman, A., J. L. Paradise, S. Block, D. J. Burch, M. R. Jacobs, and M. I. Balanescu. 1996. Efficacy of amoxicillin-clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility. Pediatr. Infect. Dis. J. 15:955-962.
16. Holford, N. H., and L. B. Sheiner. 1981. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Pharmacokinetics 6:429-453.
17. Jaffe, H. J., J. W. Biddle, C. Thornsberry, R. E. Johnson, R. E. Kaufman, G. H. Reynolds, P. J. Wiesner, and the Cooperative Study Group. 1976. National gonorrhea therapy monitoring study. In vitro antibiotic susceptibility and its correlation with treatment results. N. Engl. J. Med. 294:5-9.
18. Klassen, M., and S. C. Edberg. 1996. Measurement of antibiotics in human body fluids: techniques and significance, p. 230-295. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins Co., Baltimore, Md.
19. Kleiman, M. D., G. A. Wienbery, J. K. Reynolds, and S. D. Allen. 1993. Meningitis with beta-lactam resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatr. Infect. Dis. J. 12:782-784.
20. Leggett, J. E., B. Fantin, S. Ebert, K. Totsuka, B. Vogelman, W. Calame, H. Maftie, and W. A. Craig. 1989. Comparative antibiotic dose-effect relationships at several dosing intervals in murine pneumonitis and thigh-infection models. J. Infect. Dis. 159:281-292.
21. Moonsammy, G., R. Tucher, R. Rosen, M. Drehobl, and the LRTI/UTI Collaborative Study Group. 1996. Improved safety profile of a new amoxicillin/clavulanate (A/C) adult BID formulation compared with the standard A/C TID formulation, abstr. LM51, p. 290. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
22. Thornsberry, C., P. Ogilvie, J. Kahn, and Y. Mauriz. 1997. Surveillance of antimicrobial resistance in S. pneumoniae and H. influenzae and M. catarrhalis in the U.S. during the 1996-97 respiratory season, abstr. 53, p. 82. In Program and abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America, San Francisco, Calif.
23. Todd, P. A., and P. Benfield. 1990. Amoxicillin/clavulanic acid: an update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 39:264-307.
24. Vogleman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.